Archived DMT In The Media – 2014

4D Molecular Therapeutics Profiled in BioCentury

BioCentury, a leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government, has published an Emerging Company Profile on 4D Molecular Therapeutics. Co-founders David Schaffer and David Kirn discuss AAV gene therapy, the ...